A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING, PHASE 2 STUDY (MARS-17) OF GSK3858279 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PAIN DUE TO KNEE OSTEOARTHRITIS

Registry ID

209978

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

GLAXOSMITHKLINE INC

Start date

2023-09-19

Last update

2023-04-21

Conditions

• OSTEOARTHRITIS OF THE KNEE

Related clinical trials

• MASTER PROTOCOL: A MASTER PROTOCOL FOR PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE WEEKLY ELORALINTIDE IN ADULT PARTICIPANTS WITH OSTEOARTHRITIS KNEE PAIN, AND OBESITY OR OVERWEIGHT (ENLIGHTEN-4)
• EFFICACY AND SAFETY OF NNC0487-0111 S.C. ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY, AND KNEE OSTEOARTHRITIS (AMAZE 6)
• EFFICACY AND SAFETY OF NNC0487-0111 S.C. ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY, AND KNEE OSTEOARTHRITIS (AMAZE 5)
• A PHASE 3 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ORFORGLIPRON ONCE DAILY IN PARTICIPANTS WHO HAVE OBESITY OR OVERWEIGHT AND OSTEOARTHRITIS OF THE KNEE: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED TRIAL (ATTAIN-OA PAIN)
• SINGLE DOSE PARALLEL COMPARATIVE BIOAVAILABILITY STUDY OF TRIAMCINOLONE HEXACETONIDE FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF A SINGLE DOSE INJECTION OF TRIAMCINOLONE HEXACETONIDE (20 MG/ML) OR OF THE COMBINATION OF TRIAMCINOLONE HEXACETONIDE (18 MG/4 ML) AND CROSS-LINKED HYALURONIC ACID VISCOSUPPLEMENT IN MALE AND FEMALE PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
• RECOMBINANT HUMAN GROWTH HORMONE (RHGH) FOR KNEE OSTEOARTHRITIS (KORR): A PILOT, RANDOMIZED PLACEBO-CONTROLLED TRIAL

View on source registry